fda approval and 2 priority reviews in bladder cancer, and asco's cancer advance of the year
Published 7 years ago • 105 plays • Length 5:32
Download video MP4
Download video MP3
Similar videos
-
6:13
fda approval in carcinoid syndrome diarrhea, priority reviews in bladder cancer and nsclc, and more
-
6:59
fda approval in nsclc, priority review in bladder cancer, mbcc highlights, and more
-
6:58
fda approvals in nsclc and soft tissue sarcoma, priority review in bladder cancer, and more
-
10:46
fda approval in all, priority reviews in cml and breast cancer, and more
-
9:41
asco's cancer advance of the year, fda approval in nets, and more
-
3:19
fda approval of durvalumab for advanced bladder cancer
-
6:44
fda approval in rare leukemias, priority reviews in msi-h cancers and mcc, and more
-
34:13
digipath digest #13 – digital pathology and ai: from pd-1 to prostate cancer prognostics
-
5:46
priority reviews in bladder cancer and hcc, clinical hold lifted in myelofibrosis, and more
-
9:27
fda approval in bladder cancer, breakthrough therapy designation in dlbcl, and more
-
7:05
the fda approval of atezolizumab in bladder cancer
-
11:00
fda approval in her2 breast cancer, priority review in nsclc, and more
-
4:37
cancer advance of the year, fda approval for cinv, breakthrough designation in tnbc, and more
-
6:24
fda approval and priority review in ovarian cancer, end of part b payment model, and more
-
8:43
fda approvals in bladder cancer and nsclc, and 2019 elcc highlights
-
8:30
fda approvals in bladder cancer, nsclc, aml, hcc, and a breakthrough designation in nsclc
-
6:49
fda approval of atezolizumab for advanced bladder cancer
-
7:27
fda approvals in prostate cancer and endometrial cancer, and priority review in urothelial cancer
-
13:01
fda approvals in urothelial cancer and prostate cancer, priority review in crc, and more
Clip.africa.com - Privacy-policy